TCIM
CDLX icon

TIAA CREF Investment Management’s Cardlytics CDLX Stock Holding History

TIAA CREF Investment Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-808
Closed -$202K – 3016
2018
Q3 		$202K Buy
+808
New +$174K ﹤0.01% 2977

Other funds holding CDLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
CPV
Canaan Partners VIII Westport, Connecticut $31M AUM 45.38% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TIAA CREF Investment Management's CDLX Position: Q4 2018 in Review

TIAA CREF Investment Management sold out of Cardlytics (CDLX) in Q4 2018, closing a stake of 808 shares — an estimated $202K sold.

TIAA CREF Investment Management first reported a position in CDLX in Q3 2018 and held it in 1 quarter. The position peaked at $202K in Q3 2018. 61 funds tracked by Wall St. Rank hold CDLX as of Q4 2018.

  • TIAA CREF Investment Management reported no remaining Cardlytics position as of Q4 2018 after selling out during the quarter.
  • TIAA CREF Investment Management sold 808 Cardlytics shares in Q4 2018, an estimated $202K.
  • TIAA CREF Investment Management first reported a position in Cardlytics in Q3 2018 and held it in 1 quarter.
  • TIAA CREF Investment Management's Cardlytics position peaked at $202K in Q3 2018.
  • 61 funds tracked by Wall St. Rank held Cardlytics as of Q4 2018.

Based on TIAA CREF Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.